The Effects of Short Term Administration of a Novel Glutathione Precursor (FT061452), on Serum and Intracellular Glutathione Levels

Overview

This is a prospective randomized controlled pilot study, which will include twenty-four (24) healthy individuals between the ages of 30-65 years old to investigate the effect of a novel oral glutathione precursor, FT061452, (modified glutathione with selenium added, and cystine replacing cysteine, in doses equivalent to NAC) on serum glutathione levels and cardiovascular function. The study was designed to find out the effect of ProImmune in healthy people.

Study PI/Collaborators

Dr. Naureen Tareen at Charles Drew University

Related Grant Submission/Funded

Preparing

Abstracts

N TAREEN, J Lee, SB Nicholas, D Martins, I Sinha-Hikim, KC Norris. CLINICAL SAFETY AND EFFICACY OF A NOVEL OXIDATIVE STRESS MODULATOR (OSM). 13th RCMI International Symposium on Health Disparities, San Juan, PR. December 10-13, 2012.

Manuscripts

1st paper under development